AAAAAA
Results: 1-25/32
Authors:
El Yacoubi, M
Ledent, C
Parmentier, M
Costentin, J
Vaugeois, JM
Citation: M. El Yacoubi et al., Adenosine A(2A) receptor knockout mice are partially protected against drug-induced catalepsy, NEUROREPORT, 12(5), 2001, pp. 983-986
Authors:
Asselin, ML
Dubuc, I
Coquerel, A
Costentin, J
Citation: Ml. Asselin et al., Localization of neurotensin NTS2 receptors in rat brain, using [H-3]levocabastine, NEUROREPORT, 12(5), 2001, pp. 1087-1091
Authors:
El Yacoubi, M
Ledent, C
Parmentier, M
Ongini, E
Costentin, J
Vaugeois, JM
Citation: M. El Yacoubi et al., In vivo labelling of the adenosine A(2A) receptor in mouse brain using theselective antagonist [H-3]SCH 58261, EUR J NEURO, 14(9), 2001, pp. 1567-1570
Authors:
Naudon, L
Leroux-Nicollet, I
Boulay, D
Costentin, J
Citation: L. Naudon et al., Decreased densities of dopamine and serotonin transporters and of vesicular monoamine transporter 2 in severely kainic acid lesioned subregions of the striatum, J NEURAL TR, 108(4), 2001, pp. 431-444
Authors:
Corera, AT
Do-Rego, JC
Costentin, J
Bonnet, JJ
Citation: At. Corera et al., Differential sensitivity to NaCl for inhibitors and substrates that recognize mutually exclusive binding sites on the neuronal transporter of dopamine in rat striatal membranes, NEUROSCI RE, 39(3), 2001, pp. 319-325
Authors:
Liu, J
Dong, C
Cazin, L
Clabaut, M
Dubuc, I
Costentin, J
Coquerel, A
Citation: J. Liu et al., Developmental changes of H-3-labelled mu-opioid receptors in brainstems ofintra-uterine growth-restricted rats, DEV BRAIN R, 126(2), 2001, pp. 211-215
Authors:
Suaudeau, C
Rinaldi, D
Lepicard, E
Venault, P
Crusio, WE
Costentin, J
Chapouthier, G
Citation: C. Suaudeau et al., Divergent levels of anxiety in mice selected for differences in sensitivity to a convulsant agent (vol 71, pg 517, 2000), PHYSL BEHAV, 72(3), 2001, pp. 453-453
Authors:
El Yacoubi, M
Ledent, C
Parmentier, M
Daoust, M
Costentin, J
Vaugeois, JM
Citation: M. El Yacoubi et al., Absence of the adenosine A(2A) receptor or its chronic blockade decrease ethanol withdrawal-induced seizures in mice, NEUROPHARM, 40(3), 2001, pp. 424-432
Authors:
de Mateos-Verchere, JG
Leprince, J
Tonon, MC
Vaudry, H
Costentin, J
Citation: Jg. De Mateos-verchere et al., The octadecaneuropeptide [diazepam-binding inhibitor (33-50)] exerts potent anorexigenic effects in rodents, EUR J PHARM, 414(2-3), 2001, pp. 225-231
Authors:
Leprince, J
Oulyadi, H
Vaudry, D
Masmoudi, O
Gandolfo, P
Patte, C
Costentin, J
Fauchere, JL
Davoust, D
Vaudry, H
Tonon, MC
Citation: J. Leprince et al., Synthesis, conformational analysis and biological activity of cyclic analogs of the octadecaneuropeptide ODN - Design of a potent endozepine antagonist, EUR J BIOCH, 268(23), 2001, pp. 6045-6057
Authors:
El Yacoubi, M
Ledent, C
Parmentier, M
Bertorelli, R
Ongini, E
Costentin, J
Vaugeois, JM
Citation: M. El Yacoubi et al., Adenosine A(2A) receptor antagonists are potential antidepressants: evidence based on pharmacology and A(2A) receptor knockout mice, BR J PHARM, 134(1), 2001, pp. 68-77
Authors:
Syringas, M
Janin, F
Giros, B
Costentin, J
Bonnet, JJ
Citation: M. Syringas et al., Involvement of the NH2 terminal domain of catecholamine transporters in the Na+ and Cl--dependence of a [H-3]-dopamine uptake, BR J PHARM, 133(3), 2001, pp. 387-394
Authors:
Florin, S
Meunier, JC
Costentin, J
Citation: S. Florin et al., Autoradiographic localization of [H-3]nociceptin binding sites in the rat brain (vol 880, pg 11, 2000), BRAIN RES, 910(1-2), 2001, pp. 208-209
Authors:
El Yacoubi, M
Ledent, C
Parmentier, M
Costentin, J
Vaugeois, JM
Citation: M. El Yacoubi et al., The anxiogenic-like effect of caffeine in two experimental procedures measuring anxiety in the mouse is not shared by selective A(2A) adenosine receptor antagonists, PSYCHOPHAR, 148(2), 2000, pp. 153-163
Authors:
Nail-Boucherie, K
Dourmap, N
Jaffard, R
Costentin, J
Citation: K. Nail-boucherie et al., Contextual fear conditioning is associated with an increase of acetylcholine release in the hippocampus of rat, COGN BRAIN, 9(2), 2000, pp. 193-197
Authors:
Suaudeau, C
Rinaldi, D
Lepicard, E
Venault, P
Crusio, WE
Costentin, J
Chapouthier, G
Citation: C. Suaudeau et al., Divergent levels of anxiety in mice selected for differences in sensitivity to a convulsant agent, PHYSL BEHAV, 71(5), 2000, pp. 517-523
Authors:
Vilpoux, C
Leroux-Nicollet, I
Naudon, L
Raisman-Vozari, R
Costentin, J
Citation: C. Vilpoux et al., Reserpine or chronic paroxetine treatments do not modify the vesicular monoamine transporter 2 expression in serotonin-containing regions of the rat brain, NEUROPHARM, 39(6), 2000, pp. 1075-1082
Authors:
Corera, AT
Costentin, J
Bonnet, JJ
Citation: At. Corera et al., Binding of uptake blockers to the neuronal dopamine transporter: further investigation about cationic and anionic requirements, N-S ARCH PH, 362(3), 2000, pp. 213-221
Authors:
Syringas, M
Janin, F
Mezghanni, S
Giros, B
Costentin, J
Bonnet, JJ
Citation: M. Syringas et al., Structural domains of chimeric dopamine-noradrenaline human transporters involved in the Na+ - and Cl- -dependence of dopamine transport, MOLEC PHARM, 58(6), 2000, pp. 1404-1411
Authors:
El Yacoubi, M
Ledent, C
Parmentier, M
Costentin, J
Vaugeois, JM
Citation: M. El Yacoubi et al., SCH 58261 and ZM 241385 differentially prevent the motor effects of CGS 21680 in mice: evidence for a functional 'atypical' adenosine A(2A) receptor, EUR J PHARM, 401(1), 2000, pp. 63-77
Authors:
El Yacoubi, M
Ledent, C
Menard, JF
Parmentier, M
Costentin, J
Vaugeois, JM
Citation: M. El Yacoubi et al., The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors, BR J PHARM, 129(7), 2000, pp. 1465-1473
Authors:
Florin, S
Meunier, JC
Costentin, J
Citation: S. Florin et al., Autoradiographic localization of [H-3]nociceptin binding sites in the rat brain, BRAIN RES, 880(1-2), 2000, pp. 11-16
Authors:
Dubuc, I
Sarret, P
Labbe-Jullie, C
Botto, JM
Honore, E
Bourdel, E
Martinez, J
Costentin, J
Vincent, JP
Kitabgi, P
Mazella, J
Citation: I. Dubuc et al., Identification of the receptor subtype involved in the analgesic effect ofneurotensin, J NEUROSC, 19(1), 1999, pp. 503-510
Authors:
Condamine, E
Leprince, J
Suaudeau, C
Mayer, C
Davoust, D
Costentin, J
Vaudry, H
Citation: E. Condamine et al., The proenkephalin A-processing product peptide E, which encompasses two enkephalin sequences, has a much lower opioid activity than beta-endorphin, PEPTIDES, 20(7), 1999, pp. 865-871
Authors:
de Mateos-Verchere, JG
Leprince, J
Tonon, MC
Vaudry, H
Costentin, J
Citation: Jg. De Mateos-verchere et al., Reduction of pentylenetetrazol-induced convulsions by the octadecaneuropeptide ODN, PEPTIDES, 20(12), 1999, pp. 1431-1436